UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Strategy Inc
MSTR
|
+$745M |
| 3 |
EA
Electronic Arts
EA
|
+$725M |
| 4 |
TotalEnergies
TTE
|
+$639M |
| 5 |
Walmart Inc
WMT
|
+$585M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.87B |
| 2 |
Apple
AAPL
|
+$1.41B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 5 |
Southwest Airlines
LUV
|
+$727M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.52% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 6.68% |
| 4 | Industrials | 6.61% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6151
Tenaya Therapeutics
TNYA
$163M
| $413K | ﹤0.01% |
579,601
+382,874
| +195% | +$521K |
|
6152
Pacer Industrial Real Estate ETF
INDS
$116M
| $412K | ﹤0.01% |
11,244
-6,872
| -38% | -$260K |
|
|
MDV
6153
Modiv Industrial
MDV
| $409K | ﹤0.01% |
28,428
-2,666
| -9% | -$38.8K |
|
|
BKN
6154
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
| $408K | ﹤0.01% |
36,414
+24,865
| +215% | +$279K |
|
6155
CALL
Ribbon Communications
RBBN
$377M
| $408K | ﹤0.01% |
141,600
+200
| +0.1% | +$645 |
|
6156
Oxford Square Capital
OXSQ
$157M
| $408K | ﹤0.01% |
231,643
+133,060
| +135% | +$242K |
|
6157
Lightpath Technologies
LPTH
$953M
| $407K | ﹤0.01% |
37,703
-7,429
| -16% | -$60.2K |
|
6158
CEMIG Preferred Shares
CIG
$5.52B
| $407K | ﹤0.01% |
203,395
-1,182,872
| -85% | -$2.42M |
|
|
PPIH
6159
Perma-Pipe International
PPIH
$218M
| $406K | ﹤0.01% |
13,386
-12,848
| -49% | -$352K |
|
6160
Lyell Immunopharma
LYEL
$342M
| $406K | ﹤0.01% |
13,203
-8,039
| -38% | -$180K |
|
|
NLOP
6161
Net Lease Office Properties
NLOP
$172M
| $406K | ﹤0.01% |
15,731
-60,844
| -79% | -$1.72M |
|
6162
Global X Blockchain ETF
BKCH
$205M
| $403K | ﹤0.01% |
6,306
+3,671
| +139% | +$322K |
|
|
AISP
6163
Airship AI Holdings
AISP
$67.5M
| $402K | ﹤0.01% |
139,252
+83,625
| +150% | +$344K |
|
6164
CALL
FMC
FMC
$1.27B
| $402K | ﹤0.01% |
+29,000
| New | +$553K |
|
6165
Medifast
MED
$128M
| $402K | ﹤0.01% |
37,607
+3,850
| +11% | +$46.1K |
|
6166
Douglas Elliman
DOUG
$185M
| $401K | ﹤0.01% |
169,383
+137,029
| +424% | +$352K |
|
6167
iShares Government/Credit Bond ETF
GBF
$128M
| $400K | ﹤0.01% |
3,823
| – | – |
|
|
MPV
6168
Barings Participation Investors
MPV
$175M
| $400K | ﹤0.01% |
25,162
+1,970
| +8% | +$38.4K |
|
6169
Invesco Dorsey Wright Energy Momentum ETF
PXI
$55.5M
| $398K | ﹤0.01% |
8,808
-4,001
| -31% | -$187K |
|
6170
PUT
Sprouts Farmers Market
SFM
$7.69B
| $398K | ﹤0.01% |
+5,000
| New | +$449K |
|
|
MLGO
6171
MicroAlgo
MLGO
$47.2M
| $397K | ﹤0.01% |
89,857
+15,909
| +22% | +$126K |
|
6172
CALL
Mattel
MAT
$4.29B
| $397K | ﹤0.01% |
+20,000
| New | +$386K |
|
6173
Fate Therapeutics
FATE
$300M
| $397K | ﹤0.01% |
403,524
+88,765
| +28% | +$107K |
|
|
DMAA
6174
Drugs Made In America Acquisition Corp
DMAA
| $396K | ﹤0.01% |
38,159
+18,038
| +90% | +$186K |
|
|
BIOA
6175
BioAge Labs
BIOA
$487M
| $395K | ﹤0.01% |
29,879
-7,055
| -19% | -$62.5K |
|
Similar funds
UBS Group's Q4 2025 Portfolio in Review
As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.
- UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
- UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
- UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
- UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
- UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
- UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.